3,072 hedge funds and large institutions have $169B invested in Pfizer in 2022 Q3 according to their latest regulatory filings, with 138 funds opening new positions, 1,351 increasing their positions, 1,225 reducing their positions, and 168 closing their positions.

New
Increased
Maintained
Reduced
Closed

more call options, than puts

Call options by funds: $ | Put options by funds: $

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more ownership

Funds ownership:

less funds holding

Funds holding:

16% less capital invested

Capital invested by funds: $201B → $169B (-$32B)

18% less first-time investments, than exits

New positions opened: 138 | Existing positions closed: 168

38% less funds holding in top 10

Funds holding in top 10: 251156 (-95)

Holders
3,072
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
156
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$2.73B
Puts
$2.07B
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
26
$973M
27
$960M
28
$938M
29
$879M
30
$870M
31
$837M
32
$826M
33
$801M
34
$730M
35
$686M
36
$681M
37
$652M
38
$626M
39
$581M
40
$543M
41
$542M
42
$523M
43
$519M
44
$515M
45
$498M
46
$479M
47
$468M
48
$462M
49
$445M
50
$437M